title: Middle East respiratory syndrome vaccines.
abstract: The Middle East respiratory syndrome coronavirus (MERS-CoV) has infected over 1600 individuals with nearly 600 deaths since it was first identified in human populations in 2012. No antiviral therapies or vaccines are available for its treatment or prophylaxis. Approaches to the development of MERS vaccines are discussed herein, including a summary of previous efforts to develop vaccines useful against human and non-human coronaviruses. A striking feature of MERS is the important role that camels have in transmission. Camel vaccination may be a novel approach to preventing human infection.
authors.affiliation: Department of Microbiology, BSB 3-712, University of Iowa, 51 Newton Road, Iowa City, IA 52242, USA. Electronic address: Stanley-perlman@uiowa.edu.
authors.forename: Stanley
authors.initials: S
authors.lastname: Perlman
authors.affiliation: Department of Microbiology, BSB 3-712, University of Iowa, 51 Newton Road, Iowa City, IA 52242, USA.
authors.forename: Rahul
authors.initials: R
authors.lastname: Vijay
mesh_terms: D000818:Animals; D002162:Camelus; D018352:Coronavirus Infections / Q000517:prevention & control* / Q000821:virology; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus; D014765:Viral Vaccines
chemical_list: D014765:Viral Vaccines
keywords: Coronavirus; Human respiratory disease; Middle East respiratory syndrome; Severe acute respiratory syndrome; Vaccines